Quanjun Y. Yang

No. 600, Yishan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Identification of a candidate PRODH allosteric inhibitor MBTP-15324: modulation of proline metabolite profiles and ECM-associated gene-expression changes in lung cancer cells.

Identification of a candidate PRODH allosteric inhibitor MBTP-15324: modulation of proline metabolite profiles and ECM-associated gene-expression changes in lung cancer cells.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: August 24, 2026

BCAA metabolic reprogramming identifies BCKDK as a therapeutic target in cancer.

BCAA metabolic reprogramming identifies BCKDK as a therapeutic target in cancer.

Journal: Expert opinion on therapeutic targets

Published: July 24, 2026

Impact of house dust mite subcutaneous immunotherapy on plasma protein profiles in children with asthma

Impact of house dust mite subcutaneous immunotherapy on plasma protein profiles in children with asthma

Journal: Zhonghua yi xue za zhi

Published: April 28, 2026

Reprogramming the tumor microenvironment by rational immune gene therapy: From in vivo CRISPRa screening to combination design.

Reprogramming the tumor microenvironment by rational immune gene therapy: From in vivo CRISPRa screening to combination design.

Journal: Innovation (Cambridge (Mass.))

Published: April 07, 2026

Targeting the CD47-SIRPα phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.

Targeting the CD47-SIRPα phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.

Journal: Smart molecules : open access

Published: March 20, 2026

Commentary on clim-TIME: A paradigm shift in spatially resolved perturbation mapping of the metastatic tumor microenvironment.

Commentary on clim-TIME: A paradigm shift in spatially resolved perturbation mapping of the metastatic tumor microenvironment.

Journal: Genes & diseases

Published: March 19, 2026

A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Journal: Biomaterials science

Published: January 19, 2026

Cancer IDO1-Mediated Tryptophan-Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration.

Cancer IDO1-Mediated Tryptophan-Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration.

Journal: Journal of cachexia, sarcopenia and muscle

Published: December 07, 2025

Proline metabolism reprogramming in cancer reveals the regulation of PRODH/POX as target.

Proline metabolism reprogramming in cancer reveals the regulation of PRODH/POX as target.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 19, 2025

Fisetin Promotes Autophagy in Osteosarcoma by Activating the ROS/FOXO3 Axis via Oxidative Stress.

Fisetin Promotes Autophagy in Osteosarcoma by Activating the ROS/FOXO3 Axis via Oxidative Stress.

Journal: Phytotherapy research : PTR

Published: September 03, 2025

Coumarins in the tumor-immune application: from molecular mechanisms to therapeutic innovations.

Coumarins in the tumor-immune application: from molecular mechanisms to therapeutic innovations.

Journal: Frontiers in immunology

Published: August 08, 2025

Case Report: A pharmacist-led precision therapy framework for managing invasive fungal infection in CSF1R-Related leukoencephalopathy post Allo-HSCT.

Case Report: A pharmacist-led precision therapy framework for managing invasive fungal infection in CSF1R-Related leukoencephalopathy post Allo-HSCT.

Journal: Frontiers in pharmacology

Published: July 01, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026